Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Risk stratification in metastatic seminoma

Peter Albers, MD, University Hospital of Düsseldorf, Düsseldorf, Germany, discusses risk stratification in metastatic seminoma, one of two predominant histologic subtypes of testicular cancer. Dr Albers focuses on tailoring treatment for seminoma patients as well as reducing treatment burden. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.